Irbesartan + Hidroclorotiazida Gp

Irbesartan, the active ingredient in Irbesartan + Hydrochlorothiazide Gp, is an angiotensin II receptor blocker presented as a tablet for oral use. It lowers high blood pressure in adults. GNH USA supplies Irbesartan + Hydrochlorothiazide Gp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irbesartan/Hydrochlorothiazide acts on the renin‑angiotensin system and renal sodium handling to control elevated blood pressure. - Hypertension: reduces systolic and diastolic pressure in patients with primary hypertension. - Essential hypertension: improves blood‑pressure control when monotherapy is insufficient. - High blood pressure with fluid retention: combines vasodilation and diuresis for better overall control.

The combination may cause several adverse reactions, ranging from mild to severe.

Common Side Effects: - Dizziness: feeling light‑headed, especially after standing. - Headache: mild to moderate pain in the head region. - Fatigue: unusual tiredness or lack of energy. - Increased urination: more frequent need to void. - Electrolyte imbalance (low potassium): may cause muscle cramps. - Mild gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Acute kidney injury: sudden decline in renal function. - Allergic reactions: rash, itching, or hives. - Angioedema: swelling of face, lips, or throat. - Severe hypotension: dangerously low blood pressure. - Blood dyscrasias: rare blood cell abnormalities.

Patients should be aware of specific safety considerations before using this medication. - Monitor blood pressure: ensure therapeutic targets are reached without excessive lowering. - Assess renal function: check creatinine and eGFR periodically. - Check electrolytes: especially potassium and sodium levels. - Avoid use in pregnancy: category D, risk to the fetus. - Use caution in elderly: increased sensitivity to blood‑pressure changes. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Irbesartan/Hydrochlorothiazide can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Aliskiren (in diabetic patients): may increase risk of renal impairment. - Potassium‑sparing diuretics: can cause dangerous hyper‑kalemia. - NSAIDs: may blunt antihypertensive effect and affect kidney function.

Moderate Interactions (Monitor Closely): - Lithium: increased lithium levels may lead to toxicity. - ACE inhibitors or other ARBs: combined use raises hyper‑kalemia risk.